SCHEMBL6567516

SCHEMBL6567516

COc1ccc([CH]Cc2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 1/20 0.55
KCNH2 Q12809 1/20 0.55
PTGS2 P35354 2/20 0.54
PTGS1 P23219 1/20 0.54
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
MAPT P10636 3/20 0.50
NFE2L2 Q16236 1/20 0.50
APP P05067 1/20 0.50
TLR9 Q9NR96 1/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 5/20 0.49
LMNA P02545 3/20 0.49
POLB P06746 1/20 0.49
HTT P42858 1/20 0.48
NCOA1 Q15788 1/20 0.48
NCOA3 Q9Y6Q9 1/20 0.48
MEN1 O00255 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6014000 1.00 KCNJ1 (0.55) KCNJ1KCNH2PTGS2PTGS1MAOA
SCHEMBL1930129 0.83 ALDH1A1 (0.61) PTGS2NFE2L2ALDH1A1LMNACYP1A2
SCHEMBL7655222 0.83 ACHE (0.60) PTGS2MAOAMAOBMAPTNFE2L2
SCHEMBL322726 0.83 ACHE (0.60) PTGS2MAOAMAOBMAPTNFE2L2
SCHEMBL8021579 0.81 PTGS2 (0.63) PTGS2MAPTTLR9RAB9AALDH1A1
SCHEMBL9128800 0.81 PTGS2 (0.68) PTGS2MAPTTLR9RAB9AALDH1A1
SCHEMBL1005735 0.80 PTGS2 (0.78) PTGS2PTGS1MAOAMAOBMAPT
SCHEMBL14880486 0.80 PTGS2 (0.63) KCNJ1KCNH2PTGS2PTGS1MAOA
SCHEMBL1005734 0.80 PTGS2 (0.78) PTGS2PTGS1MAOAMAOBMAPT
SCHEMBL14880488 0.80 KCNJ1 (0.63) KCNJ1KCNH2MAPTAPPRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776382-B1 18F-SACCHARIDE-FOLATES Merck & Cie (CH) 2018-09-19 EP disclosed
EP-1086077-B1 NOVEL ANTIESTROGENS, A METHOD FOR THE PRODUCTION THEREOF, AND THEIR PHARMACEUTICAL APPLICATION SCHERING AG (DE) 2004-04-07 EP disclosed
WO-2000040612-A9 INSULIN-LIKE GROWTH FACTOR (IGF) I MUTANT VARIANTS GENENTECH INC (US) 2001-03-22 WO disclosed
US-6096883-A 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones SCHERING CORPORATION (US) 2000-08-01 US disclosed
EP-0127636-A1 COMPOUNDS CONTAINING BETA-LACTAMS BEECHAM GROUP PLC (GB) 1984-12-12 EP disclosed
WO-1984002134-A1 COMPOUNDS CONTAINING beta-LACTAMS BEECHAM GROUP PLC (GB) 1984-06-07 WO disclosed